CB vs EW · P/E 14, rev $59.40B vs P/E 47, rev $1.39B
Chubb Ltd (CB) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
CB currently screens at market cap $114.26B and trailing P/E 13.7. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the CB and EW stock pages for the full models.
Not investment advice.